These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 205784)
21. [Primary cytomegalovirus infection as a risk factor following kidney transplantation]. Kaden J; Adamczyk G; Groth J; May G; Janisch W; Scholz D; Topel WR Z Urol Nephrol; 1983 Oct; 76(10):625-32. PubMed ID: 6318475 [TBL] [Abstract][Full Text] [Related]
22. Incidence of cytomegalovirus infection and its relationship to donor-recipient serologic status in liver transplantation. Rakela J; Wiesner RH; Taswell HF; Hermans PE; Smith TF; Perkins JD; Krom RA Transplant Proc; 1987 Feb; 19(1 Pt 3):2399-402. PubMed ID: 3029918 [No Abstract] [Full Text] [Related]
23. Early diagnosis of cytomegalovirus infection in renal transplantation. Feletti C; Musiani M; Bonomini V Proc Eur Dial Transplant Assoc; 1980; 17():473-7. PubMed ID: 6264422 [No Abstract] [Full Text] [Related]
24. What are the implications of cardiac infection with cytomegalovirus before heart transplantation? Lowry RW; Adam E; Hu C; Kleiman NS; Cocanougher B; Windsor N; Bitar JN; Melnick JL; Young JB J Heart Lung Transplant; 1994; 13(1 Pt 1):122-8. PubMed ID: 8167117 [TBL] [Abstract][Full Text] [Related]
25. Absence of association between cytomegalovirus infection and obliterative transplant arteriopathy in renal allograft rejection. Nadasdy T; Smith J; Laszik Z; Waner JL; Johnson LD; Silva FG Mod Pathol; 1994 Apr; 7(3):289-94. PubMed ID: 8058700 [TBL] [Abstract][Full Text] [Related]
26. Natural killer cells and cytomegalovirus and Epstein-Barr virus infection in cardiac graft recipients. Korcáková L; Kaslík J; Svobodová J; Nozicková M; Horák J; Kocandrle V; Fabián J; Raska I; Lejnar J; Franková V Cor Vasa; 1988; 30(6):435-41. PubMed ID: 2853033 [TBL] [Abstract][Full Text] [Related]
27. A detailed study of cytomegalovirus infections in the first 160 heart and heart/lung transplant recipients at Papworth Hospital, Cambridge, England. Wreghitt TG; Hakim M; Gray JJ; Kucia S; Cory-Pearce R; Wallwork J; English TA Transplant Proc; 1987 Feb; 19(1 Pt 3):2495-6. PubMed ID: 2856284 [No Abstract] [Full Text] [Related]
28. Three-year experience with human cytomegalovirus infections in heart transplant recipients. Grossi P; Revello MG; Minoli L; Percivalle E; Zavattoni M; Poma G; Martinelli L; Gerna G J Heart Transplant; 1990; 9(6):712-9. PubMed ID: 2177498 [TBL] [Abstract][Full Text] [Related]
29. [Importance of screening for antibodies to cytomegalovirus in organ transplantation]. Milbradt H; Flik J; Stangel W; Heigel R Beitr Infusionsther; 1990; 26():33-6. PubMed ID: 1703866 [TBL] [Abstract][Full Text] [Related]
30. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients. Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902 [TBL] [Abstract][Full Text] [Related]
32. Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. van den Berg AP; Klompmaker IJ; Haagsma EB; Peeters PM; Meerman L; Verwer R; The TH; Slooff MJ Clin Transplant; 1996 Apr; 10(2):224-31. PubMed ID: 8664524 [TBL] [Abstract][Full Text] [Related]
33. Risk factors for the development of obliterative bronchiolitis after lung transplantation. Girgis RE; Tu I; Berry GJ; Reichenspurner H; Valentine VG; Conte JV; Ting A; Johnstone I; Miller J; Robbins RC; Reitz BA; Theodore J J Heart Lung Transplant; 1996 Dec; 15(12):1200-8. PubMed ID: 8981205 [TBL] [Abstract][Full Text] [Related]
34. VCAM-1 and E-selectin expression during cytomegalovirus infection in post-transplant myocardial biopsies. Allen MD; King C; MacDonald TO; Himes V Clin Transplant; 1996 Dec; 10(6 Pt 1):528-37. PubMed ID: 8996774 [TBL] [Abstract][Full Text] [Related]
35. Perspectives for the control of cytomegalovirus infections in bone marrow transplant recipients. Pollard RB; Merigan TC Transplant Proc; 1978 Mar; 10(1):241-5. PubMed ID: 205021 [No Abstract] [Full Text] [Related]
36. [Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients]. Mohacsi P; Leonardi L; Waser M; Lüthy A; Laske A; Turina M; Gallino A Ther Umsch; 1990 Feb; 47(2):157-63. PubMed ID: 2156344 [TBL] [Abstract][Full Text] [Related]
37. Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation. Rostambeigi N; Kudva YC; John S; Mailankody S; Pedersen RA; Dean PG; Prieto M; Cosio FG; Kremers WK; Walker RC; Abraham RS; Stegall MD Transplantation; 2010 May; 89(9):1126-33. PubMed ID: 20164817 [TBL] [Abstract][Full Text] [Related]
38. Evidence for pulmonary dysfunction in all patients with symptomatic and asymptomatic cytomegalovirus (CMV) infection after renal transplantation. van Son WJ; van der Bij W; The TH; Peset R; van der Mark TM; Tegzess AM Transplant Proc; 1989 Feb; 21(1 Pt 2):2065-8. PubMed ID: 2540553 [No Abstract] [Full Text] [Related]
39. Asymptomatic cytomegalovirus infection in renal transplants: treatment or no treatment. Lee PC; Hung CJ; Sung JM; Chang YT; Tsai MT; Dai YS; Liang CC; Lei HY Transplant Proc; 1996 Jun; 28(3):1513-5. PubMed ID: 8658765 [No Abstract] [Full Text] [Related]
40. Immune globulin (GAMMAGARD) prophylaxis of CMV infections in patients undergoing organ transplantation and allogeneic bone marrow transplantation. Fehir KM; Decker WA; Samo T; Young JB; Lederer E; Lawrence EC Transplant Proc; 1989 Feb; 21(1 Pt 3):3107-9. PubMed ID: 2539691 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]